v ::INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES::
ResearcherID - CLICK HERE Scientific Journal Impact Factor (SJIF-2020) - CLICK HERE

TITLE:

ASSESSMENT OF AWARENESS OF SAUDI FEMALE ABOUT COMPLICATION OF RHESUS FACTOR (RH) INCOMPATIBILITY DURING PREGNANCY IN TAIF CITY, SAUDI ARABIA

AUTHORS:

Nisreen. K. Aref , Jehan Fouad A. Sarriyah , Miad M. Althuwaybi , Alaa A. Alzahranei , Reem W. Alsuwat , Kawthar A. Bokari , Kholoud M. Aljaed , Suhaib M.Mustafa Bukhari

ABSTRACT:

Introduction: Rhesus (Rh) incompatibility is associated with the development of maternal Rh sensitization and hemolytic disease of the neonate (HDN). Studies have shown that mothers had a low level of knowledge about Rh incompatibility and its complications. The aim of this study was to assess the RH incompatibility awareness and its relation to pregnancy among Saudi females in the Taif city of Saudi Arabia. Methodology: The awareness about Rh incompatibility during pregnancy and its complications among Saudi females from Taif city were studied using an online questionnaire. The study included 224 Rh-negative females with age ranging from 18-22 year that was done from October 2019 to April 2020. Results: all participants knew their blood group, 39.7% knew about RH incompatibility, 64.7% reported that RH incompatibility leads to abortion or early labor. Of them, 84.8% said that negative blood groups need close follow up during pregnancy, 55.4% knew that negative Rh affect baby condition after delivery, and 72.8% knew that Rh incompatibility needs more care during pregnancy. Most of the participants (89.3%) reported that injection is given both before and after delivery. Conclusion: The defective knowledge regarding some aspects related to RH incompatibility necessitates a health education campaigns directed to all females. The health care professional should direct a health education message regarding this issue to their female clients, especially pregnant females. Keywords: Rh incompatibility, anti- D immunoglobulin, Saudi female

FULL TEXT

Top
  • Follows us on
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.